Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-hour FEV1 Profile of Olodaterol vs Foradil in COPD
NCT00931385Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olodaterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Jun 2009; status: completed.
02
Drugs
olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00931385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00931385.